These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11680178)

  • 21. [Treatment of colorectal carcinoma].
    Simon L; Tam B
    Orv Hetil; 2003 Oct; 144(43):2141-2. PubMed ID: 14661447
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current debates on rectal cancer].
    Lasser P
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B78-85. PubMed ID: 12068274
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
    J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer in patients over 70 years of age: determinants of outcome.
    Basdanis G; Papadopoulos VN; Michalopoulos A; Fahantidis E; Apostolidis S; Berovalis P; Zatagias A; Karamanlis E
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s112-5. PubMed ID: 15655591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invited commentary.
    Pfannschmidt J
    Ann Thorac Surg; 2010 Feb; 89(2):380. PubMed ID: 20103302
    [No Abstract]   [Full Text] [Related]  

  • 26. The current status of intraoperative radiotherapy in colorectal surgery.
    Nyam DC; Yang TL
    Singapore Med J; 1998 Sep; 39(9):422-5. PubMed ID: 9885724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progress in adjuvant therapy for colorectal cancer].
    Kohnoe S; Kakeji Y; Maehara Y
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug therapy of colorectal carcinoma].
    Ulrich-Pur H; Jech B; Scheithauer W; Kornek GV; Huber H
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):368-76. PubMed ID: 12708089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer.
    Maxwell-Armstrong C; Scholefield J
    Clin Evid; 2002 Jun; (7):406-13. PubMed ID: 12230666
    [No Abstract]   [Full Text] [Related]  

  • 32. An international multidisciplinary approach to the management of advanced colorectal cancer. The International Working Group in Colorectal Cancer (IWGCRC) (1).
    Ann Chir Gynaecol; 1998; 87(3):255-64. PubMed ID: 9825075
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of radiotherapy and chemotherapy in the treatment of colorectal cancer].
    De Llano Rodríguez I; Rodrigo Sáez L; Prados Cano D; Schleiman Helabi H
    Rev Esp Enferm Apar Dig; 1989 May; 75(5):519-26. PubMed ID: 2669051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for palliative care in advanced colorectal cancer.
    Dixon MR; Stamos MJ
    Dig Surg; 2004; 21(5-6):344-51. PubMed ID: 15467377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer.
    Maxwell-Armstrong C; Scholefield J
    Clin Evid; 2002 Dec; (8):445-52. PubMed ID: 12603893
    [No Abstract]   [Full Text] [Related]  

  • 37. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival.
    Baskaranathan S; Philips J; McCredden P; Solomon MJ
    Dis Colon Rectum; 2004 Dec; 47(12):2076-9. PubMed ID: 15657657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study.
    Gunnlaugsson A; Anderson H; Fernebro E; Kjellén E; Byström P; Berglund K; Ekelund M; Påhlman L; Holm T; Glimelius B; Johnsson A
    Eur J Cancer; 2009 Mar; 45(5):807-13. PubMed ID: 19110416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
    François E; Berdah JF; Chamorey E; Lesbats G; Teissier E; Codoul JF; Badetti JL; Hébert C; Mari V
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):931-6. PubMed ID: 18273618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors that influence treatment strategies in advanced colorectal cancer.
    Nesbitt C; Glendinning RJ; Byrne C; Poston GJ
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S88-94. PubMed ID: 18023553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.